Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Exploring the effect of genetic variability on COVID-19 infection and severity

Researchers demonstrated how narrow-sense heritability (h2) leads to variability in the susceptibility to COVID-19 infection and severity among different individuals.

27 May 2022

2-Deoxy-D-glucose may inhibit coronaviruses and rhinoviruses

Scientists demonstrated the use of 2-deoxy-D-glucose (2-DG) as a wide-spectrum antiviral agent targeting viruses such as SARS-CoV-2.

27 May 2022

Burned out by covid and 80-hour workweeks, resident physicians unionize

In the early weeks of the pandemic, Dr. Lorenzo González, then a second-year resident of family medicine at Harbor-UCLA Medical Center, ran on fumes, working as many as 80 hours a week in the ICU.

27 May 2022

Nexus Medical Labs receives FDA Emergency Use Authorization for SARS-CoV-2 test using the RHINOstic™ Automated Nasal Swab from Rhinostics

Rhinostics Inc. and Nexus Medical Labs recently received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a molecular SARS-CoV-2 test enabling unsupervised self-collection.

From Rhinostics 27 May 2022

Risk factors for COVID-19 in patients with hematological malignancies

Researchers investigate the risk factors present in individuals suffering from hematological malignancies and COVID-19.

26 May 2022

Why gyms have a higher risk of COVID

Researchers discuss the marked change in aerosol emission over a range of physical exercises.

26 May 2022

KHN’s ‘What the Health?’: A(nother) very sad week

This week's mass shooting of elementary schoolers in Texas (just 10 days after a racially motivated mass shooting at a Buffalo, New York, grocery store) has reignited the gun debate in Washington, D.C., and around the country.

26 May 2022

Cell membrane-bound enzyme is essential for SARS-CoV-2 infectivity, study shows

The membrane-bound form of angiotensin converting enzyme 2 (ACE2) is essential for enabling infection with SARS-CoV-2, the virus that causes COVID-19, according to a study published in the journal Cell.

26 May 2022

New evidence confirms that enterovirus D68 causes acute flaccid myelitis

A case report published in the New England Journal of Medicine provides evidence that enterovirus D68 directly infects spinal cord neurons and that a corresponding robust immune response is present – a direct causation to the polio-like paralyzing illness, acute flaccid myelitis (AFM).

26 May 2022

Overestimation of population immunity resulted in lack of preparedness and U.S. Delta variant surge

When the delta variant of SARS-CoV-2 hit the United States in summer 2021, it led to a larger-than-expected surge in cases, hospitalizations and deaths.

26 May 2022

Latino and Indigenous Mexican farm-working communities face high risk of COVID-19

Although everyone has been affected by COVID-19 and the pandemic it spawned, not all populations have been affected equally.

26 May 2022

Novavax missed its global moonshot but is angling to win over mRNA defectors

Novavax hitched its wagon to the global coronavirus pandemic. Before most Americans truly grasped the scope of the danger, the small Maryland biotech startup had secured $1.6 billion in U.S. funding for its covid vaccine. Its moonshot goal: delivering 2 billion shots to the world by mid-2021.

26 May 2022